Navigation Links
Approximately One-Third of MS Patients Experiencing Relapses Do Not Adequately Respond to Traditional Corticosteroid Therapy, According to New Data Presented at the 5th Joint Congress of the European and Americas Committees for Treatment and Researc
Date:10/21/2011

AMSTERDAM, Oct. 21, 2011 /PRNewswire/ -- On October 21 at the 5th Joint Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS/ACTRIMS), results were presented from a survey conducted by NARCOMS which found that about one-third of patients experiencing MS relapses do not adequately respond to corticosteroid treatment.  The survey included over 2,000 patients with MS who had experienced relapses and were treated with either intravenous (IV) or oral corticosteroids.  Corticosteroids are generally considered to be first-line therapy for MS relapses requiring therapy by most neurologists.

Of 1,122 MS patients surveyed who had been treated with IV steroids for their relapses, 31% reported no change or a worsening of relapse symptoms following treatment.  Of 894 MS patients treated with oral steroids for relapses, 39% reported no change or a worsening of symptoms following treatment.

"This NARCOMS survey helps to further our understanding about the experiences and perspectives of patients who are suffering from MS relapses," said Ruth Ann Marrie, MD, PhD, Director of the Multiple Sclerosis Clinic at the Health Sciences Centre, Winnipeg, Manitoba, Canada and NARCOMS representative.  "We hope that such information can be helpful to both physicians and patients in the management of MS."

This survey was one of an ongoing series of patient surveys independently conducted by NARCOMS on a variety of important topics related to MS patient care.  NARCOMS is a non-profit project of the Consortium of Multiple Sclerosis Centers and operates the largest North American MS patient self-report registry, with the ultimate goal of improving research, treatment and education.

"These findings provide a major step forward in the understanding of how MS patients who are suffering relapses view their experience with corticosteroid treatment, which has been the most widely-used firs
'/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Study Finds That Gastric Banding Pays for Itself In Approximately Two Years for Patients With Diabetes and Four Years for Patients Without Diabetes
2. Cell Therapeutics, Inc. Announces Institutional Investors Purchase Approximately $16.0 Million of Preferred Stock and Warrants
3. PDI Announces Contract Extension With Revenue Value of Approximately $23 Million
4. Unilife COO Makes Open Market Purchase of Approximately $250,000 in Companys Publicly Traded Shares
5. Accuray to Acquire TomoTherapy for Approximately $277 Million in Cash and Stock
6. Court Grants Preliminary Approval to Class Action Settlement that Provides Benefits Of Approximately $20 Million to Healthcare Providers that Purchased a SS1 Before January 1, 2009
7. Echo Therapeutics Receives Funding and Commitment of Approximately $5.5 Million
8. HA&W Obtains Approximately $2 M in Credits and Cash Grants for Clients Through the Therapeutic Discovery Project Program
9. The Acute Ischemic Stroke Drug Market Will Remain Relatively Flat, Increasing from $460 Million in 2009 to Approximately $610 Million in 2019
10. Consumer Reports Flu Poll: Approximately Three Out of 10 Health Care Workers Living in a Bubble, Not Getting Flu Vaccine
11. The Non-Small-Cell Lung Cancer Drug Market Will Increase From Approximately $4 Billion in 2009 to More Than $6.5 Billion in 2019
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... , July 3, 2015 ... heute bekannt, vorbehaltlich bestimmter Abschlussbedingungen eine 100-prozentige ... erworben zu haben. Mit dieser Übernahme dringt ... mit einem Umsatz von 765 Mrd. RUB ... Pharmamärkten der Welt gehörte (IMS Health). Seit ...
(Date:7/2/2015)... -- BGI a annoncé aujourd,hui que son laboratoire ... à Hong Kong avait ...  (Collège des pathologistes américains, ou CAP). Les installations ... constituent le premier laboratoire clinique de séquençage ... CAP en Chine, car il satisfait les normes ...
(Date:7/2/2015)... 2, 2015  New product launches are critical events ... in educating thought leaders about new products, Medical Affairs ... how well a new therapy performs at launch. ... and consulting leader Best Practices, LLC, critical aspects of ... on are early stage thought leader (TL) interaction, successful ...
Breaking Medicine Technology:Lupin übernimmt Biocom aus Russland 2Lupin übernimmt Biocom aus Russland 3BGI obtient la certification du Collège des pathologistes américains (CAP) 2Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2
... , ATLANTA, Oct. 27 CryoLife, Inc. ... and cardiovascular tissue processing company, today announced that the U.S. ... company,s Investigational Device Exemption (IDE) to conduct a human clinical ... protein hydrogel technology. BioFoam will be used to help ...
... 27 STAAR Surgical Company (Nasdaq: STAA ), a ... today announced today that Deborah Andrews, Chief Financial Officer, will ... Waldorf-Astoria Hotel on Wednesday, November 4th at 3:55 p.m. Eastern ... audio web cast of the presentation at www.staar.com ...
Cached Medicine Technology:CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R) 2CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R) 3CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R) 4CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R) 5
(Date:7/4/2015)... ... ... a hacker gains access to someone’s email account, it can lead to all sorts of ... the FTC issued a scam alert about a social engineering scam which cons a ... instigated by the hacker. All they have to do is click for a password ...
(Date:7/3/2015)... ... 04, 2015 , ... The Harvest Hope Food Bank will hopefully be getting a ... offices in the area of Greenville SC are making it their mission to collect ... only. They are asking for donations from the public as well. As part of the ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... ... Dori Friend opened registration for a new SEO training system called "Page ... guide for organic traffic generation has received glowing reviews from several well-known marketers. ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Scientists at ... susceptible to mesothelioma with even minimal asbestos exposure. Click here to read the ... the University of Hawaii Cancer Center, Cedars Sinai Medical Center, and New York University ...
(Date:7/3/2015)... LENEXA, Kan. (PRWEB) , ... July 03, 2015 ... ... firm dedicated exclusively to healthcare providers, has been retained to lead a national ... the top-ranked executive search firms in the healthcare industry, B. E. Smith has ...
Breaking Medicine News(10 mins):Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 3Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 4Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3
... FL (October 5, 2011)Approximately 10-20 percent of prostate cancer patients ... three major factors that are used to evaluate the extent ... estimate prognosis: the Prostate Specific Antigen Level (PSA), Gleason ... findings (DRE). However, men with a family history of ...
... , WEDNESDAY, Oct. 5 (HealthDay News) -- Smokers have ... are more likely than men to suffer complications after a ... data on 3,588 patients admitted to the University of Michigan ... attack. About 24 percent of the patients were current smokers. ...
... seven days after a severe head injury results in better ... College of Medicine researchers. This is especially true for patients ... the hospital. A tracheostomy is an opening created in ... allow unimpeded breathing. (A tracheotomy is the act of making ...
... Targets and Cancer Therapeutics will be held from Nov. ... Francisco. This unique conference combines the efforts ... Cancer Institute and the European Organisation for the Research ... of its kind to focus exclusively on issues of ...
... Tool That Helps Identify Prostate Cancer Patients with the ... 4, 2011)After a prostate cancer patient receives radiation treatment, ... or PSA, in his blood. An increase in PSA, ... the cancer,s return to the prostate. Fox Chase Cancer ...
... known to improve motor function in,recovering stroke patients, appear ... units (ICU), new research from Johns,Hopkins suggests. In ... Critical Care ,researchers studied the safety and feasibility of ... ICU. "Patients admitted to our medical intensive care ...
Cached Medicine News:Health News:More aggressive treatment not necessary for men with a family history of prostate cancer 2Health News:Earlier tracheostomies result in better patient outcomes 2Health News:New tool helps identify prostate cancer patients with highest risk of death 2Health News:Practical play: Interactive video games appear valuable for ICU patients 2
Manual Lensmeter....
The Marco Lensmeter 201 features internal readings for the presbyopic practitioner or those who prefer to work in subdued lighting where external readings are difficult....
... A crisp 2.3 million pixel ... the retinal surface for all ... disc evaluation for glaucoma to ... way to provide filmless, instant ...
Manual lensmeter with AO target, high and wide field eyepiece and better marking dots....
Medicine Products: